SPR Therapeutics awarded $6 million U.S. Department of Defense grant

Story excerpt provided by Crain’s Cleveland Business.

Written by Lydia Coutré.

SPR Therapeutics has secured a $6 million contract from the U.S. Department of Defense for its non-opioid pain management therapy.

The four-year contract will help to advance SPR’s SPRINT Peripheral Nerve Stimulation (PNS) System for non-opioid relief of acute and chronic pain. The contract complements a previously awarded defense department grant of $2.8 million, bringing the total department awards to nearly $9 million to advance research and commercialization of the therapy, according to a news release.

Click here to read the complete article.

Originally published May 15, 2017.